Sandy Spring Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sandy Spring Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-850	Closed	-$105K	–	1276
2023 Q4	$105K	Hold	850	–	–	0.01%	445
2023 Q3	$110K	Hold	850	–	–	0.01%	425
2023 Q2	$105K	Hold	850	–	–	0.01%	433
2023 Q1	$124K	Hold	850	–	–	0.01%	399
2022 Q4	$135K	Hold	850	–	–	0.01%	377
2022 Q3	$113K	Hold	850	–	–	0.01%	392
2022 Q2	$133K	Hold	850	–	–	0.01%	370
2022 Q1	$132K	Hold	850	–	–	0.01%	387
2021 Q4	$108K	Hold	850	–	–	0.01%	430
2021 Q3	$111K	Hold	850	–	–	0.01%	405
2021 Q2	$151K	Hold	850	–	–	0.01%	365
2021 Q1	$140K	Hold	850	–	–	0.01%	353
2020 Q4	$140K	Hold	850	–	–	0.01%	344
2020 Q3	$121K	Buy	+850	New	+$105K	0.01%	345
2016 Q3	–	Sell	-16	Closed	-$2K	–	855
2016 Q2	$2K	Hold	16	–	–	﹤0.01%	852
2016 Q1	$2K	Hold	16	–	–	﹤0.01%	888
2015 Q4	$2K	Hold	16	–	–	﹤0.01%	864
2015 Q3	$2K	Hold	16	–	–	﹤0.01%	871
2015 Q2	$3K	Hold	16	–	–	﹤0.01%	866
2015 Q1	$3K	Hold	16	–	–	﹤0.01%	816
2014 Q4	$3K	Hold	16	–	–	﹤0.01%	753
2014 Q3	$3K	Hold	16	–	–	﹤0.01%	733
2014 Q2	$2K	Hold	16	–	–	﹤0.01%	760
2014 Q1	$2K	Buy	+16	New	+$2.41K	﹤0.01%	708
2013 Q4	–	Sell	-73	Closed	-$7K	–	684
2013 Q3	$7K	Hold	73	–	–	﹤0.01%	575
2013 Q2	$5K	Buy	+73	New	+$4.46K	﹤0.01%	574

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sandy Spring Bank's JAZZ Position: Q1 2024 in Review

Sandy Spring Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 850 shares — an estimated $105K sold.

Sandy Spring Bank first reported a position in JAZZ in Q2 2013 and held it in 26 quarters. The position peaked at $151K in Q2 2021. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Sandy Spring Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Sandy Spring Bank sold 850 Jazz Pharmaceuticals shares in Q1 2024, an estimated $105K.
Sandy Spring Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 26 quarters.
Sandy Spring Bank's Jazz Pharmaceuticals position peaked at $151K in Q2 2021.
481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Sandy Spring Bank's 13F filing for Q1 2024, filed 8 May 2024.